Seclect Currency
Fiat currencies
Crypto Currencies
No results for ""
We couldn't find anything matching your search.Try again with a different term.
Tharimmune
Overview Fundraising
Overview
Location
Unknown
Launched
--
Category
Subcategory
--
Fundraising Round
Post-IPO
Valuation
--
Cumulative Amount
$540M
About Tharimmune
Tharimmune, Inc. (THAR) is a clinical-stage biotechnology company developing a portfolio of therapeutic candidates for inflammation and immunology.
Fundraising
Post-IPO
Date: November 4, 2025
Amount: $540M
Valuation: --
| Investors | Type | Location | Year Founded | # Portfolio Companies | Email Address | Socials |
|---|---|---|---|---|---|---|
| Fund | United States of America | 2012 | 35 | [email protected] | ||
| Fund | United States of America | 1992 | 14 | -- | ||
| Corporate | -- | -- | 50 | -- | ||
| Fund | United States of America | 2016 | 182 | [email protected] | ||
| Corporate | United States of America | 2014 | 4 | -- |
Disclaimer: This page showcases the projects or companies that have secured angel funding from various investors (corporations, funds, individuals, etc.). Most of these projects or companies are related to blockchain, but some also involve other fields like metaverse, artificial intelligence, etc. Being listed on this page does not imply that these projects or companies have issued or will issue any coins or tokens in the future.